Login / Signup
V N Antonov
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 9
Top Topics
Ejection Fraction
Lung Function
Extracorporeal Membrane Oxygenation
Chronic Obstructive Pulmonary Disease
Top Venues
Terapevticheskii arkhiv
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
V N Antonov
,
G L Ignatova
[Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies].
Terapevticheskii arkhiv
95 (3) (2023)
V N Antonov
,
G L Ignatova
[Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies].
Terapevticheskii arkhiv
95 (3) (2023)
V N Antonov
,
G L Ignatova
[Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies].
Terapevticheskii arkhiv
95 (3) (2023)
G L Ignatova
,
V N Antonov
[Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease].
Terapevticheskii arkhiv
94 (11) (2022)
G L Ignatova
,
V N Antonov
[Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease].
Terapevticheskii arkhiv
94 (11) (2022)
G L Ignatova
,
E V Blinova
,
V N Antonov
[Analysis of the clinical efficacy of vaccination against pneumococcal infection in patients with chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus].
Terapevticheskii arkhiv
94 (1) (2022)
G L Ignatova
,
V N Antonov
[Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease].
Terapevticheskii arkhiv
94 (11) (2022)
G L Ignatova
,
V N Antonov
,
E A Makarova
,
S A Kochetkova
[Experience of using dupilumab in the treatment of severe asthma].
Terapevticheskii arkhiv
92 (8) (2020)
V N Antonov
,
G L Ignatova
,
O V Pribytkova
,
S S Sleptsova
,
E A Strebkova
,
E A Khudyakova
,
A I Simakova
,
S Y Rabets
,
E P Tihonova
,
D Y Kurmaeva
,
M A Petrushin
,
A S Mashkov
,
E V Gayazova
,
I V Yasheva
,
M A Andreev
,
V V Khinovker
,
A Y Karpunin
,
B V Berezhanskiy
[Experience of olokizumab use in COVID-19 patients].
Terapevticheskii arkhiv
92 (12) (2020)